The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2022 | Interpreting real-world data to better manage patients with mCRC
Chiara Cremolini, MD, PhD, University of Pisa, Pisa, Italy, provides an overview of the of real-world data in patients with metastatic colorectal cancer (mCRC), highlighting its use as post-marketing data which may make clinicians more confident in the use of novel therapies. Obtaining real-world data allows the collation of more information in heterogenous populations, provides information on long-term follow-up as well as a better understanding of clinical outcomes in underrepresented populations. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
